MPO and chronic obstructive pulmonary disease: Of note, the MPO inhibition has been found to suppress the progression of CS-induced physiological alterations of COPD, such as emphysema and small airway and pulmonary arterial remodeling in animal models [72–74], supporting the role of MPO in COPD.